Shopify Inc. vs Tenet Healthcare Corporation — how do they compare? Shopify Inc. trades at $165.34 (market cap $211.73B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Shopify Inc. is far larger — about 10.1× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 7,146,651). Which is the better fit depends on your goals — on Pluang, investors hold Shopify Inc. for 78 Days and Tenet Healthcare Corporation for 15 Days on average.
| SHOP | THC | |
|---|---|---|
Market Cap | $211.73B | $20.98B |
Volume | 7,146,651 | 428,008 |
Sector | Technology | Health |
52-Week High | $179.01 | $280.77 |
52-Week Low | $95.40 | $161.37 |
Typical Hold Time | 78 Days | 15 Days |
Enterprise Value | $206.96B | $32.06B |
Signals from Pluang's Aura AI — not financial advice
Shopify (SHOP) trades at $165.94, up 0.88% today, showing strong momentum near analyst consensus targets. The stock maintains a bullish technical outlook with solid fundamental growth - revenue increased from $5.6B in 2022 to $11.6B in 2025 while achieving profitability. Recent earnings show mixed results with Q4 2025 missing estimates but Q1 and Q2 2026 beating expectations. The company continues to innovate with AI-powered commerce tools and expanding merchant solutions.
Shopify presents growth potential through e-commerce leadership and AI integration, though elevated valuation metrics (P/E 112, P/S 16) warrant caution. Key risks include competitive pressures from Amazon and valuation sensitivity to growth sustainability. Analyst consensus remains bullish with 67% buy ratings and $168.63 price target, suggesting modest upside from current levels.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →